ovr.news
About

Mozambique expands artificial intelligence platform to improve vaccination coverage

Read on observador.pt · 8 November 2026
Mozambique expands artificial intelligence platform to improve vaccination coverage
Photo: observador.pt
2 related sources

Headline and summary by local AI

Zenysis Technologies, in partnership with the Ministério da Saúde de Moçambique and supported by Gavi (Aliança para as Vacinas), is expanding an artificial intelligence platform to more than 80 districts in six provinces in Mozambique.

The platform, known as the Advanced Data Analytics Platform (PAAD), integrates information from over ten different health systems into a single location. This allows health authorities to monitor vaccination indicators, vaccine availability, and service performance in one place.

The expansion addresses a critical public health challenge where 24% of Mozambican children have received no routine vaccines. The tool helps health teams identify areas with low coverage, find data inconsistencies, and locate specific communities with gaps in immunization. By centralizing data, the platform reduces the time required for officials to consolidate and analyze information.

Alberto Jacenau, a provincial immunization official in Zambézia, stated that the tool allows him to complete analyses in a fraction of the time it previously took using Excel. The technology was first used during the response to Cyclone Idai in 2019. During that period, officials integrated cholera outbreak data into a virtual operations room, which helped reduce cases in the Sofala province from approximately 400 per day to zero in less than a month.

Recent data from Unicef and the Organização Mundial da Saúde (OMS) show that the coverage of the third dose of the diphtheria, tetanus, and pertussis vaccine (DTP3) rose from 55% in 2022 to 70% in 2023.

Selected and summarized by local AI How we work

More in Solutions

Browse all Solutions articles

Anything you want to add?

What made you doubt it?

What's wrong with this article?